Detalhe da pesquisa
1.
Cardiovascular risk in chronic myeloid leukaemia: A multidisciplinary consensus on screening and management.
Eur J Haematol
; 111(2): 201-210, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186398
2.
Bleeding related hospitalizations and mortality in England 2014-2019.
J Thromb Thrombolysis
; 56(2): 233-240, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338712
3.
UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey.
BMC Nephrol
; 24(1): 9, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635661
4.
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.
Thromb Haemost
; 124(4): 324-336, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527782
5.
Assessment of current clinical practice throughout the UK for the diagnosis and management of monoclonal gammopathy of renal significance.
EJHaem
; 4(2): 410-418, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206284
6.
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK.
Curr Med Res Opin
; 39(3): 483-495, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629478
7.
A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease.
J Nephrol
; 35(8): 2015-2033, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006608